Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Choroidal neovascularization secondary to cuticular drusen treated with intravitreal bevacizumab
Rowan G B Porter1, Samyukta B Karki
1*VMO, Centre for Excellence in Indigenous Health, Brisbane, Australia; and †Porter Eye Care, Brisbane, Australia.
Purpose:
To report our experience with intravitreal injection of bevacizumab in the treatment of cuticular drusen-associated choroidal neovascularization.
Methods:
An interventional case report. A 38-year-old woman presented with decreased visual acuity in her right eye and cuticular drusen-associated choroidal neovascularization.
Results:
Prolonged (12 months) remission of choroidal neovascularization after 3 monthly bevacizumab injections with improvement in visual acuity from 20/120 to 20/20.
Conclusion:
The use of antivascular endothelial growth factor in the management of cuticular drusen-associated choroidal neovascularization seems to be an effective method of treatment showing both resolution of optical coherence tomography changes and improvement in visual acuity in this case. However, further studies with bigger sample size and longer follow-up are required to confirm the findings.
More Related Videos
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Diabetic Retinopathy